Paper2596777
Busulphan and phenytoin.
Grigg AP and 2 others. Ann Intern Med, 1989. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Busulphan and phenytoin. Papers, record 2596777. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2596777
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Busulfan | Major topic |
| Phenytoin | Major topic |
| Seizures | Major topic |
| Adult | |
| Humans |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40319193 | Mechanisms underlying seizures and hypothermia during busulphan administration. | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/40319193 | PubMed |
| 35004543 | A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia. | Front Pediatr | 2021 | https://conductscience.org/library/papers/35004543 | PubMed |
| 34546410 | Neurological complications in Chinese children undergoing hematopoietic stem cell transplantation. | Childs Nerv Syst | 2021 | https://conductscience.org/library/papers/34546410 | PubMed |
| 30915718 | Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation. | Int J Hematol | 2019 | https://conductscience.org/library/papers/30915718 | PubMed |
| 28490733 | Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients. | Sci Rep | 2017 | https://conductscience.org/library/papers/28490733 | PubMed |
| 19361744 | Busulfan in hematopoietic stem cell transplantation. | Biol Blood Marrow Transplant | 2009 | https://conductscience.org/library/papers/19361744 | PubMed |
| 18679372 | Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18679372 | PubMed |
| 12098063 | Lorazepam for seizure prophylaxis during high-dose busulfan administration. | Bone Marrow Transplant | 2002 | https://conductscience.org/library/papers/12098063 | PubMed |
| 10523796 | The role of busulfan in bone marrow transplantation. | Med Oncol | 1999 | https://conductscience.org/library/papers/10523796 | PubMed |
| 8324869 | Disposition of total and unbound etoposide following high-dose therapy. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8324869 | PubMed |
| 8269597 | Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8269597 | PubMed |
| 2265459 | The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2265459 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2596777
GET https://conductscience.org/api/papers/v1/2596777/authors